Centrally-administered opioid selective agonists inhibit drinking in the rat

Robert L. Spencer, David Deupree, Sigmund Hsiao, Henry I. Mosberg, Victor Hruby, Thomas F. Burks, Frank Porreca

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


The effects of intracerebroventricular injection of mu (morphine), kappa (dynorphin-(1-13), ethylketocyclazocine, and U50,488H), and delta ([D-Pen2,D-Pen5]enkephalin) opioid agonists on water intake of 14 hr water deprived rats was studied. All agonists caused a dose related decrease in time spent drinking, with a rank order potency of dynorphin-(1-13) > morphine > ethylketocyclazocine >[D-Pen2,D-Pen5]enkephalin = U50,488H. With the exception of morphine, all of the compounds increased the latency to begin drinking, but only at the highest doses tested. The rank order potency for this endpoint was dynorphin-(1-13) = ethylketocyclazocine > [D-Pen2,D-Pen5]enkephalin > U503, 488H. The potent inhibition of drinking following centrally-given dynorphin-(1-13), at doses that did not affect the latency to begin drinking, supports a role for endogenous dynorphin in the homeostatic control of water balance. This function may not be primarily mediated through activation of a kappa opioid receptor since dynorphin-(1-13) was 80-230 times more potent than the selective kappa agonist, U50,488H or ethylketocyclazocine.

Original languageEnglish (US)
Pages (from-to)77-82
Number of pages6
JournalPharmacology, Biochemistry and Behavior
Issue number1
StatePublished - Jul 1986


  • Drinking
  • Dynorphin
  • Opioids
  • Water balance

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience


Dive into the research topics of 'Centrally-administered opioid selective agonists inhibit drinking in the rat'. Together they form a unique fingerprint.

Cite this